학술논문

Current and Past Immunodeficiency Are Associated With Higher Hospitalization Rates Among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years
Document Type
article
Source
The Journal of Infectious Diseases. 224(4)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Infectious Diseases
Sexually Transmitted Infections
Clinical Research
Anti-HIV Agents
CD4 Lymphocyte Count
Canada
Cohort Studies
Female
HIV Infections
Hospitalization
Humans
Male
Viral Load
HIV/AIDS
6.1 Pharmaceuticals
HIV
hospitalization
CD4 lymphocyte count
sustained virologic response
cohort studies
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA
Biological Sciences
Medical and Health Sciences
Microbiology
Biological sciences
Biomedical and clinical sciences
Health sciences
Language
Abstract
BackgroundPersons with HIV (PWH) with persistently low CD4 counts despite efficacious antiretroviral therapy could have higher hospitalization risk.MethodsIn six US and Canadian clinical cohorts, PWH with virologic suppression for ≥1 year in 2005-2015 were followed until virologic failure, loss to follow-up, death, or study end. Stratified by early (Years 2-5) and long-term (Years 6-11) suppression and lowest pre-suppression CD4 count 500 cells/μL had an aIRR of 1.44 during early suppression (95% CI 1.01-2.06), and 1.67 (1.03-2.72) during long-term suppression. Among patients with lowest pre-suppression CD4 ≥200 (56%), patients with current CD4 351-500 versus >500 cells/μL had an aIRR of 1.22 (0.93-1.60) during early suppression and 2.09 (1.18-3.70) during long-term suppression.ConclusionsVirologically suppressed patients with lower CD4 counts experienced higher hospitalization rates, and could potentially benefit from targeted clinical management strategies.